Kuopio, Finland

Jukka Matti Leppanen


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jukka Matti Leppanen: Innovator in Medicinal Chemistry

Introduction

Jukka Matti Leppanen is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating medical conditions related to dopamine receptor activity. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing healthcare solutions.

Latest Patents

Jukka holds a patent for a compound described as a medicament intended for use in treating medical conditions characterized by an imbalance in dopamine receptor activity. This patent highlights his focus on addressing critical health issues through scientific innovation. The patent is a testament to his commitment to improving patient outcomes and enhancing therapeutic options.

Career Highlights

Throughout his career, Jukka has been associated with Motac Neuroscience Limited, where he has played a pivotal role in research and development. His work has not only contributed to the company's mission but has also positioned him as a key figure in the field of neuroscience. His dedication to research and innovation has earned him recognition among his peers.

Collaborations

Jukka has collaborated with esteemed colleagues, including Holger Stark and Britta Caroline Sasse. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their collective work in the field of medicinal chemistry.

Conclusion

Jukka Matti Leppanen is a distinguished inventor whose contributions to medicinal chemistry are noteworthy. His patent reflects his innovative spirit and commitment to addressing significant health challenges. Through his work at Motac Neuroscience Limited and collaborations with talented colleagues, he continues to make strides in the field, ultimately benefiting patients and the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…